Cargando…

Impact of Exogenous Treatment with Histidine on Hepatocellular Carcinoma Cells

SIMPLE SUMMARY: Sorafenib (Nexavar@) is the only currently approved anti-cancer drug for patients with advanced hepatocellular carcinoma (HCC). However, despite the development of strategies combining sorafenib with other cytotoxic chemotherapeutic agents to overcome sorafenib resistance, clinical t...

Descripción completa

Detalles Bibliográficos
Autores principales:	Park, Yusun, Han, Yeonju, Kim, Dongwoo, Cho, Sua, Kim, WonJin, Hwang, Hyemin, Lee, Hye Won, Han, Dai Hoon, Kim, Kyung Sik, Yun, Mijin, Lee, Misu
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8909034/ https://www.ncbi.nlm.nih.gov/pubmed/35267513 http://dx.doi.org/10.3390/cancers14051205

Ejemplares similares

Extracellular Citrate Treatment Induces HIF1α Degradation and Inhibits the Growth of Low-Glycolytic Hepatocellular Carcinoma under Hypoxia
por: Kim, Seon Yoo, et al.
Publicado: (2022)

Modulation of SIRT3 expression through CDK4/6 enhances the anti-cancer effect of sorafenib in hepatocellular carcinoma cells
por: Jo, Hanhee, et al.
Publicado: (2020)

Elevated miR-16-5p induces somatostatin receptor 2 expression in neuroendocrine tumor cells
por: Jo, HanHee, et al.
Publicado: (2020)

Modified parylene-N films as chemical microenvironments for differentiation and spheroid formation of osteoblast cells
por: Kim, Tae-Hun, et al.
Publicado: (2020)

Regulation of Acetate Utilization by Monocarboxylate Transporter 1 (MCT1) in Hepatocellular Carcinoma (HCC)
por: Jeon, Jeong Yong, et al.
Publicado: (2018)

Cancer Metabolism as a Mechanism of Treatment Resistance and Potential Therapeutic Target in Hepatocellular Carcinoma
por: Lee, Misu, et al.
Publicado: (2018)

Metabolic tumour volume on (18)F-FDG PET/CT predicts extended pathological T stages in patients with renal cell carcinoma at staging
por: Kim, Dongwoo, et al.
Publicado: (2021)

Glycolysis on F-18 FDG PET/CT Is Superior to Amino Acid Metabolism on C-11 Methionine PET/CT in Identifying Advanced Renal Cell Carcinoma at Staging
por: Lee, Suk-Hyun, et al.
Publicado: (2021)

Hepatocellular Carcinoma Risk According to Regimens for Eradication of Hepatitis C Virus; Interferon or Direct Acting Antivirals
por: Lee, Hye Won, et al.
Publicado: (2020)

Appraisal of Long-Term Outcomes of Liver-Directed Concurrent Chemoradiotherapy for Hepatocellular Carcinoma with Major Portal Vein Invasion
por: Han, Sojung, et al.
Publicado: (2020)

The critical role of glucose deprivation in epithelial-mesenchymal transition in hepatocellular carcinoma under hypoxia
por: Jo, Hanhee, et al.
Publicado: (2020)

Exogenous rhTRX reduces lipid accumulation under LPS-induced inflammation
por: Han, Gi-Yeon, et al.
Publicado: (2014)

Development and validation of a prognostic model for patients with hepatocellular carcinoma undergoing radiofrequency ablation
por: Kim, Chang Gon, et al.
Publicado: (2019)

A Case of Lymphocyte-Rich Hepatocellular Carcinoma in a Patient Who Was Treated for Colon Cancer
por: Song, Jae Won, et al.
Publicado: (2021)

Serum Sorbitol Dehydrogenase as a Novel Prognostic Factor for Hepatocellular Carcinoma after Surgical Resection
por: Jeon, Dongsub, et al.
Publicado: (2021)

Exogenous addition of histidine reduces copper availability in the yeast Saccharomyces cerevisiae
por: Watanabe, Daisuke, et al.
Publicado: (2014)

Genetic variations in histidine-rich protein 2 and histidine-rich protein 3 of Myanmar Plasmodium falciparum isolates
por: Lê, Hương Giang, et al.
Publicado: (2020)

Dextran-b-poly(L-histidine) copolymer nanoparticles for ph-responsive drug delivery to tumor cells
por: Hwang, Jong-ho, et al.
Publicado: (2013)

Glucose Loading Enhances the Value of (18)F-FDG PET/CT for the Characterization and Delineation of Cerebral Gliomas
por: Kim, Dongwoo, et al.
Publicado: (2020)

Histidine residues at the copper-binding site in human tyrosinase are essential for its catalytic activities
por: Noh, Hyangsoon, et al.
Publicado: (2020)

Effects of exogenous emulsifier supplementation on growth performance, energy digestibility, and meat quality in broilers
por: An, Ji Seon, et al.
Publicado: (2020)

CTHRC1 activates pro-tumorigenic signaling pathways in hepatocellular carcinoma
por: Wang, Yunpeng, et al.
Publicado: (2017)

Anti-Cancer Effects of YAP Inhibitor (CA3) in Combination with Sorafenib against Hepatocellular Carcinoma (HCC) in Patient-Derived Multicellular Tumor Spheroid Models (MCTS)
por: Han, Sojung, et al.
Publicado: (2022)

Performance of Momguard, a new non-invasive prenatal testing protocol developed in Korea
por: Lee, Mi-Young, et al.
Publicado: (2015)

A novel prognostic factor for hepatocellular carcinoma: protein disulfide isomerase
por: Yu, Su Jong, et al.
Publicado: (2014)

Predictors of Complete Response in Patients with Hepatocellular Carcinoma Treated with Trans-Arterial Radioembolization
por: Kim, Yuna, et al.
Publicado: (2021)

Negligible risks of hepatocellular carcinoma during biomarker-defined immune-tolerant phase for patients with chronic hepatitis B
por: Jeon, Mi Young, et al.
Publicado: (2021)

Clinical characteristics and prognosis of Korean patients with hepatocellular carcinoma with respect to etiology
por: Jang, Wonjoon, et al.
Publicado: (2022)

Hydrophilic Linear Peptide with Histidine and Lysine Residues as a Key Factor Affecting Antifungal Activity
por: Park, Seong-Cheol, et al.
Publicado: (2018)

An intestinal model with a finger-like villus structure fabricated using a bioprinting process and collagen/SIS-based cell-laden bioink
por: Kim, WonJin, et al.
Publicado: (2020)

Hybrid cell constructs consisting of bioprinted cell‐spheroids
por: Kim, WonJin, et al.
Publicado: (2022)

Concurrent Chemoradiotherapy Shows Long-Term Survival after Conversion from Locally Advanced to Resectable Hepatocellular Carcinoma
por: Lee, Ik Jae, et al.
Publicado: (2014)

Conditional survival estimate in patients with Barcelona Clinic Liver Cancer stage B/C hepatocellular carcinoma treated with hepatic arterial infusion chemotherapy with/without concurrent radiotherapy
por: Cho, In Rae, et al.
Publicado: (2017)

Roles of Protein Histidine Phosphatase 1 (PHPT1) in Brown Adipocyte Differentiation
por: Kang, Joo Ae Kang Hyun Sup, et al.
Publicado: (2020)

Effects of Low-Protein Diets and Exogenous Protease on Growth Performance, Carcass Traits, Intestinal Morphology, Cecal Volatile Fatty Acids and Serum Parameters in Broilers
por: Ndazigaruye, Gervais, et al.
Publicado: (2019)

Prognosis of Early-Stage Hepatocellular Carcinoma: Comparison between Trans-Arterial Chemoembolization and Radiofrequency Ablation
por: Yun, Byung-Yoon, et al.
Publicado: (2020)

Validation of Pre-/Post-TACE-Predict Models among Patients with Hepatocellular Carcinoma Receiving Transarterial Chemoembolization
por: Kim, David Sooik, et al.
Publicado: (2021)

Synergistic antitumor activity of sorafenib and MG149 in hepatocellular carcinoma cells
por: Moon, Byul, et al.
Publicado: (2022)

Reactive oxygen species-induced activation of Yes-associated protein-1 through the c-Myc pathway is a therapeutic target in hepatocellular carcinoma
por: Cho, Yuri, et al.
Publicado: (2020)

The FIB-4 Index Is a Useful Predictor for the Development of Hepatocellular Carcinoma in Patients with Coexisting Nonalcoholic Fatty Liver Disease and Chronic Hepatitis B
por: Kim, Minah, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_71aobuthhe68li8o1s79hk6nnk